The impact of Parkinson's disease on health status, health expenditures, and productivity: Estimates from the National Medical Expenditure Survey

PharmacoEconomics

Volumn 12, Issue 4, 1997, Pages 486-498

  Rubenstein, Linda M ^a   Chrischilles, Elizabeth A ^a   Voelker, Margaret D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DAILY LIFE ACTIVITY; DISABILITY; ECONOMICS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; MENTAL HEALTH; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0030867180     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199712040-00006     Document Type: Article

References (42)

1. Lilienfeld DE. An epidemiological overview of amyotrophic lateral sclerosis, Parkinson's disease, and dementia of the Alzheimer type. In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: WB Saunders. 1994: 399-425
2. McDowell FH. Parkinson's disease and related disorders. In: Hazzard WR, Bierman EL, Blass JP, et al., editors, Principles of geriatric medicine and gerontology, 3rd ed, New York: McGraw-Hill Inc., 1994: 1051-61
3. Tanner CM. Epidemiology of Parkinson's disease. Neurol Clin 1992; 10(2): 317-29
4. Koller WC, editor. Handbook of Parkinson's disease. New-York: Marcel Dekker Inc., 1987
5. de Rijk MC, Breteler MMB, Graveland GA, et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology 1995; 45: 2143-6
6. Schoenberg BS, Anderson DW, Haerer AF. Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi. Neurology 1985; 35: 841-5
7. Lilienfeld DE, Perl DP. Projected neurodegenerative disease mortality in the United States. 1990-2040. Neuroepidemiology 1993; 12: 219-28
8. Fearnley J, Lees A. Pathology of Parkinson's disease. In: Calne DB. editor. Neurodegenerative diseases. Philadelphia: WB Saunders, 1994: 545-54
9. Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992; 149 (4): 443-54
10. Saint-Cyr JA, Taylor AE, Lang AE. Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease. Neurology 1993; 43 Suppl. 6: S47-53
11. Pirozzolo FJ, Swihart AA, Rey GJ, et al. Cognitive impairments associated with Parkinson's disease and other movement disorders. In: Jankovic J, Tolosa E, editors. Parkinson's disease and movement disorders. 2nd ed. Baltimore: Williams & Wilkins, 1993: 493-510
12. van Dijk JG, Haan J, Zwinderman K, et al. Autonomie nervous system dysfunction in Parkinson's disease: relationships with age. medication, duration, and severity. J Neurol Neurosurg Psychiatry 1993; 56 (10): 1090-5
13. Marsden CD, Fahn S. Problems in Parkinson's disease and other akinetic-rigid syndromes. In: Marsden CD, Fahn S, editors. Movement Disorders. Vol. 3. Boston: Butterworth-Heinemann Ltd., 1994: 117-23
14. Stoessl AJ. Prevention and management of late stage complications in Parkinson's disease. Can J Neurol Sci 1992; 19 Suppl. 1: 113-6
15. Fitzsimmons B, Bunting LK. Parkinson's disease: quality of life issues. Nurs Clin North Am 1993; 28 (4): 807-18
16. Nanton V. The consequences of Parkinson's disease: needs, provisions and initiatives. J R Soc Health 1985; 105 (2): 52-4
17. Singer E. The social costs of Parkinson's disease. J Chronic Dis 1973; 26: 243-54
18. Peto V, Jenkinson C, Fitzpatrick R, et al. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995; 4: 241-8
19. Berry RA, Murphy JF. Well-being of caregivers of spouses with Parkinson's disease. Clin Nurs Res 1995; 4 (4): 373-86
20. Clarke CE, Zobkiw RM, Gullaksen E. Quality of life and care in Parkinson's disease. Br J Clin Pract 1995; 49 (6): 288-93
21. Shindler JS, Brown R, Welburn P, et al. Measuring the quality of life of patients with Parkinson's disease. In: Walker SR, Rosser RM, editors. Quality of life assessment: key issues in the 1990's. Boston: Kluwer Academic Publishers, 1993: 289-300
22. Jenkinson C, Peto V, Fitzpatrick R, et al. Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ 39). Age Ageing 1995; 24(6): 505-9
23. de Boer AG, Wijker W, Speelman JD, et al. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996; 61 (1): 70-4
24. Martiney-Marlin P, Frades Payo B, Fontan Tirado C, et al. Assessing quality of life in Parkinson's disease using the PDQ-39: a pilot study [in Spanish]. Neurologia 1997; 12 (2): 56-60
25. Hubson P, Meara J. Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the Short-Form 36 and the Parkinson's Disease Questionnaire [letter]. Age Ageing 1996; 25 (4): 334-5
26. Dodel RC, Pepperl S, Kohne-Volland R, et al. Costs of drug treatment of neurologic diseases: Parkinson's disease, dystonia. epilepsy (review of 64 references) [in German]. Med Klin 1996; 91 (7): 479-85
27. Chrischilles EA, Rubenstein LM, Voelker MD, et al. The burdens of Parkinson's disease. Mov Disord. In press
28. Eisenberg JM. Clinical economics: a guide to the economic-analysis of clinical practices. JAMA 1989; 262: 2879-86
29. Edwards W, Berlin M. Questionnaires and data collection methods for the Household Survey and the Survey of American Indians and Alaska Natives Roekville (MD): Public Health Service, 1989 Sep. DHHS publication no.: (PHS) 89-3450. (National Medical Expenditure Survey Methods; 2) (National Center for Health Services Research and Health Care Technology Assessment)
30. US Department of Health and Human Services. The international classification of diseases. 9th. rev. Clinical modifications. Vol. I. Washington, DC: US Government Printing Office, 1980
31. Katz S, Ford AB, Moskowitz RN, et al. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 185: 914-28
32. Lawton M, Brody E. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-87
33. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I conceptual framework and item selection. Med Care 1992; 30 (6): 473-83
34. Fahn S, Elton RL. members of the Unified Parkinson's Disease Rating Scale (UPDRS) Development Committee. Unified Parkinson's Disease Rating: Scale. In: Fahn S, Marsden CD, Calne D, et al., editors. Recent Developments in Parkinson's Disease II. Vol. 2. Florham Park (NJ): MacMillan Healthcare Information, 1987; 153-63: 243-304
35. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman and Hall, 1993
36. SAS Institute Inc. SAS/STAT user's guide. Release 6.03 ed. Cary (NO: SAS Institute Inc., 1988
37. Bruce PC. User guide for resampling stats software. IBM version 3.14, 1973-1993. Arlington (VA): Resampling Stats, Inc., 1993
38. Ware JE. SF-36 health survey: manual and interpretation guide. Boston: The Health Institute, New England Medical Center, 1993
39. Ellgring H, Seiler S, Perleth B, et al. Psychosocial aspects of Parkinson's disease. Neurology 1993 ; 43 Suppl. 6 : S41-4
40. Anderson DW, Schoenberg BS, Haerer AF. Prevalence surveys ot neurologic disorders: methodologic implications of the Copiah county study. J Clin Epidemiol 1988; 41 (4): 339-45
41. Lilienfeld DE, Sprafka JM, Pham DL, et al. Parkinson's and motorneuron disease morbidity in the twin cities metropolitan area: 1979-1984. Neuroepidemiology 1991; 10: 112-6
42. Roman G, Zhang Z, Ellenberg JH. The neuroepidemiology of Parkinson's disease. In: Fllenberg JH, Koller WC, Langston JW. editors. Etiology of Parkinson's disease Vol. 40. New York: Marcel Dekker, 1995: 203-43